CTLA4 and rheumatoid arthritis: Indeed, several studies reported an overall decrease in peripheral Tregs in kidney transplant recipients or rheumatoid arthritis patients treated with Nulojix® or Orencia®, which are CTLA4-Ig molecules binding CD80/86 and preventing CD28-mediated costimulation [56], [57], [58].